Blue Cap AG

The company maintains a debt-to-equity ratio of 0.8, indicating a relatively balanced capital structure with manageable leverage. Its current ratio of 1.65 suggests adequate short-term liquidity to cover immediate obligations. However, the risk assessment highlights a medium liquidity risk, with a key flag noting that net cash is negative after subtracting total debt.

Profitability metrics show a return on equity (ROE) of 13.94% and a return on assets (ROA) of 6.14%, both of which are strong indicators of efficient capital use and asset management. These figures are well above the industry median for investment management firms, suggesting the company is outperforming its peers in terms of profitability and returns.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification may expose the company to higher operational and market risks, particularly in volatile economic environments. The absence of segment or geographic breakdown in the financial data limits the ability to assess exposure to specific markets or product lines.

Looking ahead, the company is projected to maintain a stable growth trajectory, with no significant revenue growth or decline expected in the next fiscal year. The current fiscal year's operating income of 939,000 EUR and net income of 13,260,000 EUR suggest a consistent earnings pattern, though the operating margin is relatively thin at 0.46%.

The risk assessment indicates a low dilution risk, with no immediate pressure from share issuance or dilutive events. The company's capital structure remains stable, and there are no recent filings or transcripts indicating plans for equity financing or share buybacks. The absence of dilution risk is a positive sign for long-term shareholders.

Recent events and filings do not show any material changes in the company's operations or strategic direction. The company's financial performance remains consistent with historical trends, and there are no disclosed regulatory or legal issues that could impact future operations. Analysts have provided a mean price target of 29.95 EUR, with a median of 30.15 EUR, and a mean recommendation of 1.75, indicating a generally positive outlook from the investment community.